A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate if topical ASC-J9 cream is effective in treating acne.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AndroScience Corp
• Treatments: Androgens

Criteria

Inclusion Criteria:

• At least 12 years of age.

• Facial acne, with:

20 -100 inflammatory facial lesions 20 -100 noninflammatory facial lesions No more than 2 nodules/cysts on the face

Exclusion Criteria:

• Women who are pregnant or breastfeeding

• Skin diseases other than acne vulgaris

• Use of oral retinoids within 6 months of Baseline Visit

• Unwilling to discontinue all other treatments for facial acne

• Unwilling to avoid excessive swimming/sun exposure and use of cosmetics